Cargando…

Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain

Neuroinflammation is a key element of AD pathology and conceivably a result of a disturbed resolution. Resolution of inflammation is an active process which is strictly orchestrated following the acute inflammatory response after removal of the inflammatory stimuli. Acute inflammation is actively te...

Descripción completa

Detalles Bibliográficos
Autores principales: Emre, Ceren, Hjorth, Erik, Bharani, Krishna, Carroll, Steven, Granholm, Ann‐Charlotte, Schultzberg, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018009/
https://www.ncbi.nlm.nih.gov/pubmed/31912564
http://dx.doi.org/10.1111/bpa.12812
_version_ 1783674151809056768
author Emre, Ceren
Hjorth, Erik
Bharani, Krishna
Carroll, Steven
Granholm, Ann‐Charlotte
Schultzberg, Marianne
author_facet Emre, Ceren
Hjorth, Erik
Bharani, Krishna
Carroll, Steven
Granholm, Ann‐Charlotte
Schultzberg, Marianne
author_sort Emre, Ceren
collection PubMed
description Neuroinflammation is a key element of AD pathology and conceivably a result of a disturbed resolution. Resolution of inflammation is an active process which is strictly orchestrated following the acute inflammatory response after removal of the inflammatory stimuli. Acute inflammation is actively terminated by specialized pro‐resolving mediators (SPMs) thereby promoting healing and return to homeostasis. Failed resolution may contribute to persistent neuroinflammation and aggravate AD pathology. BLT1 (leukotriene B(4) receptor) and ChemR23 (chemerin receptor 23) are receptors for the SPM resolvin (Rv) E1 and are important clinical targets for ending inflammation. In AD, the levels of SPMs are decreased, and pro‐inflammatory mediators are increased. In the current study, the distribution of BLT1 and ChemR23 receptors in control brains and in AD as well as correlations with AD pathology was examined for the first time. BLT1 and ChemR23 were analyzed in different regions of post‐mortem human brain from cases with AD, early‐onset AD and mild cognitive impairment (MCI) and healthy controls, using western blotting and immunohistochemistry. BLT1 and ChemR23 were detected in neurons and glial cells in all examined regions of the human brain, with markedly higher levels in AD than in controls. The receptor levels correlated with the density of staining for the inflammation markers HLA‐DR and YKL‐40 for microglia and astrocytes, respectively, and elevated staining coincided with high Braak stages in AD. The relative staining densities of these receptors were higher in the basal forebrain, cingulate gyrus and hippocampal regions compared to the cerebellum and frontal cortex (BA46). In conclusion, alterations in the expression of the resolution receptor BLT1 in AD have not been reported previously and the changes in both BLT1 and ChemR23 suggest a disturbed resolution pathway in several regions of the AD brain that may play a role in disease pathology.
format Online
Article
Text
id pubmed-8018009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80180092021-09-03 Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain Emre, Ceren Hjorth, Erik Bharani, Krishna Carroll, Steven Granholm, Ann‐Charlotte Schultzberg, Marianne Brain Pathol Research Articles Neuroinflammation is a key element of AD pathology and conceivably a result of a disturbed resolution. Resolution of inflammation is an active process which is strictly orchestrated following the acute inflammatory response after removal of the inflammatory stimuli. Acute inflammation is actively terminated by specialized pro‐resolving mediators (SPMs) thereby promoting healing and return to homeostasis. Failed resolution may contribute to persistent neuroinflammation and aggravate AD pathology. BLT1 (leukotriene B(4) receptor) and ChemR23 (chemerin receptor 23) are receptors for the SPM resolvin (Rv) E1 and are important clinical targets for ending inflammation. In AD, the levels of SPMs are decreased, and pro‐inflammatory mediators are increased. In the current study, the distribution of BLT1 and ChemR23 receptors in control brains and in AD as well as correlations with AD pathology was examined for the first time. BLT1 and ChemR23 were analyzed in different regions of post‐mortem human brain from cases with AD, early‐onset AD and mild cognitive impairment (MCI) and healthy controls, using western blotting and immunohistochemistry. BLT1 and ChemR23 were detected in neurons and glial cells in all examined regions of the human brain, with markedly higher levels in AD than in controls. The receptor levels correlated with the density of staining for the inflammation markers HLA‐DR and YKL‐40 for microglia and astrocytes, respectively, and elevated staining coincided with high Braak stages in AD. The relative staining densities of these receptors were higher in the basal forebrain, cingulate gyrus and hippocampal regions compared to the cerebellum and frontal cortex (BA46). In conclusion, alterations in the expression of the resolution receptor BLT1 in AD have not been reported previously and the changes in both BLT1 and ChemR23 suggest a disturbed resolution pathway in several regions of the AD brain that may play a role in disease pathology. John Wiley and Sons Inc. 2020-01-21 /pmc/articles/PMC8018009/ /pubmed/31912564 http://dx.doi.org/10.1111/bpa.12812 Text en © 2020 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Emre, Ceren
Hjorth, Erik
Bharani, Krishna
Carroll, Steven
Granholm, Ann‐Charlotte
Schultzberg, Marianne
Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
title Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
title_full Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
title_fullStr Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
title_full_unstemmed Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
title_short Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain
title_sort receptors for pro‐resolving mediators are increased in alzheimer's disease brain
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018009/
https://www.ncbi.nlm.nih.gov/pubmed/31912564
http://dx.doi.org/10.1111/bpa.12812
work_keys_str_mv AT emreceren receptorsforproresolvingmediatorsareincreasedinalzheimersdiseasebrain
AT hjortherik receptorsforproresolvingmediatorsareincreasedinalzheimersdiseasebrain
AT bharanikrishna receptorsforproresolvingmediatorsareincreasedinalzheimersdiseasebrain
AT carrollsteven receptorsforproresolvingmediatorsareincreasedinalzheimersdiseasebrain
AT granholmanncharlotte receptorsforproresolvingmediatorsareincreasedinalzheimersdiseasebrain
AT schultzbergmarianne receptorsforproresolvingmediatorsareincreasedinalzheimersdiseasebrain